SEC Form 4 · accession 0001209191-15-071908
Insys Therapeutics, Inc. · INSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael L Babich
Officer — President and CEO · Director
Period of report
Sep 22, 2015
Accepted (ET)
Sep 22, 2015 · 6:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001516479
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 22, 2015 | M | 16,068 | $1.62 | A | 421,572 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4,F2,F3 | $1.62 | Sep 22, 2015 | M | 16,068 | D | — | Mar 27, 2021 | Common Stock | 16,068 | 70,000 | D |
Explanation of responses
- F1On June 5, 2015, the Issuer effected a 2-for-1 forward stock split pursuant to a stock dividend, resulting in the reporting person's ownership of 202,752 additional shares.
- F2The exercise price reflects a 2-for-1 forward stock split effected by the Issuer on June 5, 2015.
- F3The option vested in 48 equal monthly installments and was fully vested and exercisable on March 28, 2015.
- F4On June 5, 2015, the Issuer effected a 2-for-1 forward stock split pursuant to a stock dividend, resulting in the reporting person's ownership of 43,034 additional options.